Clinical Trial: Dose Escalation of BCX10013 in Participants with Paroxysmal Nocturnal Hemoglobinuria (PNH)
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Paroxysmal Nocturnal Hemoglobinuria
Study Type: INTERVENTIONAL
Official Title: An Open-Label, Multicenter, Intra-Subject Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Therapeutic Potential of BCX10013 in Subjects with Paroxys
Brief Summary:
This is a multicenter, open-label, intra-subject, dose escalation study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and therapeutic potential of BCX10013 in participants with PNH.Approximately 8 participants will be enrolled in this study.Participants may receive treatment for up to 52 weeks.
Read more